REBASTINIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C30H28FN7O3
Molecular Weight	553.5868
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of REBASTINIB

Structure Search

SMILES

CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=NN3C4=CC=C5N=CC=CC5=C4)C(C)(C)C)C(F)=C2)=C1

InChI

InChIKey=WVXNSAVVKYZVOE-UHFFFAOYSA-N

InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)

HIDE SMILES / InChI

Molecular Formula	C30H28FN7O3
Molecular Weight	553.5868
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 01:49:52 UTC 2023` Edited by `admin` on `Sat Dec 16 01:49:52 UTC 2023`
Record UNII	75017Q6I97
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

REBASTINIB

Official Name

English

DP-1919

Code

English

rebastinib [INN]

Common Name

English

REBASTINIB [USAN]

Common Name

English

N-(3-(1,1-DIMETHYLETHYL)-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5-YL)-N'-(2-FLUORO-4-((2- (METHYLCARBAMOYL)PYRIDIN-4-YL)OXY)PHENYL)UREA

Systematic Name

English

2-PYRIDINECARBOXAMIDE, 4-(4-((((3-(1,1-DIMETHYLETHYL)-1-(6-QUINOLINYL)-1H-PYRAZOL-5-YL)AMINO)CARBONYL)AMINO)-3-FLUOROPHENOXY)-N-METHYL-

Systematic Name

English

4-(4-(((3-TERT-BUTYL-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5-YL)CARBAMOYL(AMINO)-3-FLUOROPHENOXY)-N-METHYLPYRIDIN-2-CARBOXAMIDE

Common Name

English

Rebastinib [WHO-DD]

Common Name

English

DCC-2036 FREE BASE

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C129825

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

FDA ORPHAN DRUG

637018

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

Code System Code Type Description

FDA UNII

75017Q6I97

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

PUBCHEM

25066467

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

ChEMBL

CHEMBL1738757

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

CAS

1020172-07-9

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

NCI_THESAURUS

C152162

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

SMS_ID

100000163525

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

EVMPD

SUB177831

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

EPA CompTox

DTXSID40144533

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

USAN

ZZ-63

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

DRUG BANK

DB13005

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

INN

9685

Created by admin on Sat Dec 16 01:49:52 UTC 2023 , Edited by admin on Sat Dec 16 01:49:52 UTC 2023

PRIMARY

Related Record Type Details


					WF082S23P7

BCR-ABL KINASE T315I MUTANT (IMATINIB RESISTANT)

TARGET -> INHIBITOR

Qualification:

IC50

Amount:


					1Y8BY3M6Y9

TARGET -> INHIBITOR

Qualification:

IC50

Amount:

Related Record Type Details


					75017Q6I97

ACTIVE MOIETY

Amount: